Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0427 Transporter Info | ||||
Gene Name | SLC5A7 | ||||
Transporter Name | High affinity choline transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Lung squamous cell carcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Hypomethylation of SLC5A7 in lung squamous cell carcinoma | [ 1 ] | |||
Epigenetic Type |
Methylation | Experiment Method | TCGA database | ||
Related Molecular Changes |
Up regulation of SLC5A7 | Experiment Method | RNAseq | ||
Studied Phenotype |
Lung squamous cell carcinoma [ ICD-11: 2C25.2] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SLC5A7 was upregulated and hypomethylated in lung squamous cell carcinoma. | ||||
Lung adenocarcinoma |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Hypermethylation of SLC5A7 in lung adenocarcinoma | [ 1 ] | |||
Epigenetic Type |
Methylation | Experiment Method | TCGA database | ||
Related Molecular Changes |
Down regulation of SLC5A7 | Experiment Method | RNAseq | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SLC5A7 had increased methylation and decreased expression in lung squamous cell carcinoma | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
5'UTR (cg06662812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.32E+00 | Statistic Test | p-value: 1.88E-03; Z-score: 2.91E+00 | ||
Methylation in Case |
2.89E-01 (Median) | Methylation in Control | 2.19E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
5'UTR (cg07186154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.84E+00 | Statistic Test | p-value: 1.98E-03; Z-score: 4.86E+00 | ||
Methylation in Case |
2.76E-01 (Median) | Methylation in Control | 1.49E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 6.79E-03; Z-score: 1.96E+00 | ||
Methylation in Case |
3.22E-01 (Median) | Methylation in Control | 2.77E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg03983336) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 2.78E-03; Z-score: 1.83E+00 | ||
Methylation in Case |
7.57E-01 (Median) | Methylation in Control | 6.45E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg17679621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.76E-02; Z-score: 1.49E+00 | ||
Methylation in Case |
3.67E-01 (Median) | Methylation in Control | 3.02E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg11355135) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.69E+00 | Statistic Test | p-value: 2.29E-04; Z-score: 6.09E+00 | ||
Methylation in Case |
4.29E-01 (Median) | Methylation in Control | 2.54E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg14613271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.63E+00 | Statistic Test | p-value: 2.02E-03; Z-score: 3.73E+00 | ||
Methylation in Case |
2.21E-01 (Median) | Methylation in Control | 1.35E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.73E+00 | Statistic Test | p-value: 4.00E-03; Z-score: 4.99E+00 | ||
Methylation in Case |
2.67E-01 (Median) | Methylation in Control | 1.54E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg18771173) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 8.92E-03; Z-score: 1.68E+00 | ||
Methylation in Case |
1.59E-01 (Median) | Methylation in Control | 1.15E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg05311412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.51E+00 | Statistic Test | p-value: 2.81E-02; Z-score: 2.60E+00 | ||
Methylation in Case |
1.71E-01 (Median) | Methylation in Control | 1.13E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC5A7 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 3.75E-02; Z-score: -1.68E+00 | ||
Methylation in Case |
7.66E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
5'UTR (cg06662812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.43E+00 | Statistic Test | p-value: 6.68E-08; Z-score: -1.09E+00 | ||
Methylation in Case |
3.42E-01 (Median) | Methylation in Control | 4.89E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
5'UTR (cg07186154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 8.18E-08; Z-score: 1.45E+00 | ||
Methylation in Case |
4.69E-01 (Median) | Methylation in Control | 3.50E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 4.77E-06; Z-score: -1.16E+00 | ||
Methylation in Case |
6.78E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.23E-03; Z-score: -1.96E-01 | ||
Methylation in Case |
7.51E-01 (Median) | Methylation in Control | 7.72E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in bladder cancer | [ 3 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 1.37E-02; Z-score: -2.66E+00 | ||
Methylation in Case |
1.64E-01 (Median) | Methylation in Control | 1.92E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg17052964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 6.81E-05; Z-score: 4.27E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 6.84E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg03983336) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 2.01E-03; Z-score: 3.53E+00 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 6.71E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in bladder cancer | [ 3 ] | |||
Location |
TSS200 (cg11355135) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.55E+00 | Statistic Test | p-value: 9.78E-03; Z-score: -3.89E+00 | ||
Methylation in Case |
1.05E-01 (Median) | Methylation in Control | 1.63E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in bladder cancer | [ 3 ] | |||
Location |
Body (cg14772660) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.33E+00 | Statistic Test | p-value: 1.13E-11; Z-score: -1.38E+01 | ||
Methylation in Case |
3.51E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
5'UTR (cg06662812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 1.73E-11; Z-score: 2.36E+00 | ||
Methylation in Case |
2.42E-01 (Median) | Methylation in Control | 1.70E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.40E+00 | Statistic Test | p-value: 1.63E-09; Z-score: 1.64E+00 | ||
Methylation in Case |
2.37E-01 (Median) | Methylation in Control | 1.69E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
5'UTR (cg07186154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.07E+00 | Statistic Test | p-value: 7.77E-08; Z-score: 1.62E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 7.49E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg17679621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.39E+00 | Statistic Test | p-value: 2.83E-09; Z-score: 2.57E+00 | ||
Methylation in Case |
3.99E-01 (Median) | Methylation in Control | 2.87E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 5.81E-08; Z-score: -2.15E+00 | ||
Methylation in Case |
6.98E-01 (Median) | Methylation in Control | 7.90E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg03983336) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.40E-02; Z-score: 8.98E-01 | ||
Methylation in Case |
7.28E-01 (Median) | Methylation in Control | 6.76E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg11355135) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.79E+00 | Statistic Test | p-value: 1.91E-15; Z-score: 3.20E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 2.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.80E+00 | Statistic Test | p-value: 6.10E-15; Z-score: 3.48E+00 | ||
Methylation in Case |
2.73E-01 (Median) | Methylation in Control | 7.18E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg18771173) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.04E+00 | Statistic Test | p-value: 2.20E-13; Z-score: 5.13E+00 | ||
Methylation in Case |
2.00E-01 (Median) | Methylation in Control | 4.95E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg14613271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.41E+00 | Statistic Test | p-value: 5.22E-12; Z-score: 2.84E+00 | ||
Methylation in Case |
1.52E-01 (Median) | Methylation in Control | 6.29E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg05311412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.93E+00 | Statistic Test | p-value: 8.82E-12; Z-score: 3.09E+00 | ||
Methylation in Case |
1.69E-01 (Median) | Methylation in Control | 4.29E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 3.20E-08; Z-score: -2.11E+00 | ||
Methylation in Case |
6.98E-01 (Median) | Methylation in Control | 7.65E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC5A7 in breast cancer | [ 4 ] | |||
Location |
Body (cg14772660) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.47E-03; Z-score: -3.14E-01 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
5'UTR (cg07186154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.14E+00 | Statistic Test | p-value: 2.51E-05; Z-score: 1.24E+00 | ||
Methylation in Case |
9.25E-02 (Median) | Methylation in Control | 4.32E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.88E-08; Z-score: -3.91E+00 | ||
Methylation in Case |
8.85E-01 (Median) | Methylation in Control | 9.65E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg17679621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.49E+00 | Statistic Test | p-value: 1.69E-05; Z-score: 2.44E+00 | ||
Methylation in Case |
3.78E-01 (Median) | Methylation in Control | 2.54E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.78E+00 | Statistic Test | p-value: 7.58E-06; Z-score: 2.39E+00 | ||
Methylation in Case |
9.18E-02 (Median) | Methylation in Control | 3.30E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg18771173) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.31E+00 | Statistic Test | p-value: 3.61E-03; Z-score: 1.45E+00 | ||
Methylation in Case |
4.25E-02 (Median) | Methylation in Control | 3.24E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg05311412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 4.11E-03; Z-score: 2.49E+00 | ||
Methylation in Case |
4.41E-02 (Median) | Methylation in Control | 3.10E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg14613271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 4.53E-03; Z-score: 1.81E+00 | ||
Methylation in Case |
5.39E-02 (Median) | Methylation in Control | 4.06E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 3.59E-06; Z-score: -2.08E+00 | ||
Methylation in Case |
8.47E-01 (Median) | Methylation in Control | 9.02E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg26279668) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.98E+00 | Statistic Test | p-value: 2.28E-07; Z-score: 6.24E+00 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 2.70E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg13563026) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 1.08E-05; Z-score: -2.24E+00 | ||
Methylation in Case |
2.67E-01 (Median) | Methylation in Control | 3.46E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg14918082) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 5.85E-06; Z-score: 1.24E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 6.42E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg26062856) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 5.90E-04; Z-score: -4.00E+00 | ||
Methylation in Case |
5.57E-01 (Median) | Methylation in Control | 6.51E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg19645639) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.52E+00 | Statistic Test | p-value: 7.10E-04; Z-score: -1.56E+00 | ||
Methylation in Case |
2.48E-01 (Median) | Methylation in Control | 3.76E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg09530407) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.67E+00 | Statistic Test | p-value: 6.65E-04; Z-score: 2.97E+00 | ||
Methylation in Case |
2.67E-01 (Median) | Methylation in Control | 1.60E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg00465739) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 3.32E-06; Z-score: -2.34E+00 | ||
Methylation in Case |
3.54E-01 (Median) | Methylation in Control | 5.30E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg14857792) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.33E-05; Z-score: -3.01E+00 | ||
Methylation in Case |
5.41E-01 (Median) | Methylation in Control | 6.79E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
5'UTR (cg07186154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.94E+00 | Statistic Test | p-value: 1.96E-21; Z-score: 7.43E+00 | ||
Methylation in Case |
4.31E-01 (Median) | Methylation in Control | 1.09E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
5'UTR (cg06662812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.31E+00 | Statistic Test | p-value: 2.04E-06; Z-score: 1.56E+00 | ||
Methylation in Case |
6.06E-01 (Median) | Methylation in Control | 4.63E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 1.09E-05; Z-score: 1.07E+00 | ||
Methylation in Case |
3.21E-01 (Median) | Methylation in Control | 2.46E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 1.88E-12; Z-score: -4.65E+00 | ||
Methylation in Case |
7.14E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg17679621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.80E-05; Z-score: 1.47E+00 | ||
Methylation in Case |
5.55E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg05311412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.43E+00 | Statistic Test | p-value: 7.78E-17; Z-score: 6.69E+00 | ||
Methylation in Case |
4.05E-01 (Median) | Methylation in Control | 9.14E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg14613271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.02E+00 | Statistic Test | p-value: 1.23E-14; Z-score: 4.45E+00 | ||
Methylation in Case |
3.65E-01 (Median) | Methylation in Control | 1.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg18771173) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.86E+00 | Statistic Test | p-value: 1.20E-13; Z-score: 3.78E+00 | ||
Methylation in Case |
3.93E-01 (Median) | Methylation in Control | 1.37E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg11355135) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.51E+00 | Statistic Test | p-value: 4.63E-13; Z-score: 3.14E+00 | ||
Methylation in Case |
6.93E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.45E+00 | Statistic Test | p-value: 1.21E-12; Z-score: 3.29E+00 | ||
Methylation in Case |
5.49E-01 (Median) | Methylation in Control | 2.24E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 5.76E-11; Z-score: -4.54E+00 | ||
Methylation in Case |
7.91E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC5A7 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg14772660) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 4.45E-08; Z-score: -4.05E+00 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
16 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 2.53E-02; Z-score: 1.16E-02 | ||
Methylation in Case |
1.95E-01 (Median) | Methylation in Control | 1.94E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
5'UTR (cg06662812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 3.63E-02; Z-score: 1.60E-01 | ||
Methylation in Case |
2.05E-01 (Median) | Methylation in Control | 1.99E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg19645639) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.43E+00 | Statistic Test | p-value: 2.01E-19; Z-score: -2.46E+00 | ||
Methylation in Case |
1.64E-01 (Median) | Methylation in Control | 4.00E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg09454187) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.55E+00 | Statistic Test | p-value: 1.26E-15; Z-score: -5.20E+00 | ||
Methylation in Case |
4.75E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg01109535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 2.14E-13; Z-score: -2.02E+00 | ||
Methylation in Case |
3.35E-01 (Median) | Methylation in Control | 4.51E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg00826767) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 1.03E-10; Z-score: -1.76E+00 | ||
Methylation in Case |
4.85E-01 (Median) | Methylation in Control | 6.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg17052964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 3.37E-08; Z-score: -2.02E+00 | ||
Methylation in Case |
5.42E-01 (Median) | Methylation in Control | 6.72E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 1.14E-06; Z-score: -1.29E+00 | ||
Methylation in Case |
5.57E-01 (Median) | Methylation in Control | 6.46E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg03983336) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 3.58E-05; Z-score: -1.16E+00 | ||
Methylation in Case |
4.91E-01 (Median) | Methylation in Control | 5.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg11264635) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.57E+00 | Statistic Test | p-value: 7.55E-21; Z-score: -4.89E+00 | ||
Methylation in Case |
4.00E-01 (Median) | Methylation in Control | 6.27E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.28E+00 | Statistic Test | p-value: 6.37E-04; Z-score: 4.39E-01 | ||
Methylation in Case |
1.46E-01 (Median) | Methylation in Control | 1.14E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg15027358) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.87E+00 | Statistic Test | p-value: 2.27E-21; Z-score: -1.32E+01 | ||
Methylation in Case |
4.44E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg09358975) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.79E+00 | Statistic Test | p-value: 8.64E-21; Z-score: -4.39E+00 | ||
Methylation in Case |
4.13E-01 (Median) | Methylation in Control | 7.41E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg12933431) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.56E+00 | Statistic Test | p-value: 1.69E-16; Z-score: -2.32E+00 | ||
Methylation in Case |
4.23E-01 (Median) | Methylation in Control | 6.61E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg08739738) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.55E+00 | Statistic Test | p-value: 9.11E-12; Z-score: -2.35E+00 | ||
Methylation in Case |
4.10E-01 (Median) | Methylation in Control | 6.33E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 16 |
Methylation of SLC5A7 in hepatocellular carcinoma | [ 8 ] | |||
Location |
3'UTR (cg16920502) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.76E+00 | Statistic Test | p-value: 2.66E-18; Z-score: -5.99E+00 | ||
Methylation in Case |
4.13E-01 (Median) | Methylation in Control | 7.30E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
5'UTR (cg07186154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.39E+00 | Statistic Test | p-value: 6.93E-07; Z-score: 2.82E+00 | ||
Methylation in Case |
1.80E-01 (Median) | Methylation in Control | 7.52E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
5'UTR (cg06662812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.40E+00 | Statistic Test | p-value: 4.10E-06; Z-score: 2.19E+00 | ||
Methylation in Case |
2.20E-01 (Median) | Methylation in Control | 1.57E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
5'UTR (cg20547653) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.41E+00 | Statistic Test | p-value: 1.46E-05; Z-score: 2.72E+00 | ||
Methylation in Case |
2.21E-01 (Median) | Methylation in Control | 1.57E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.86E-02; Z-score: -6.46E-01 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 8.68E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg17679621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 2.99E-02; Z-score: 5.48E-01 | ||
Methylation in Case |
4.21E-01 (Median) | Methylation in Control | 3.89E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg17052964) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.60E-02; Z-score: 4.07E-01 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 6.91E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.40E+00 | Statistic Test | p-value: 1.37E-05; Z-score: 2.79E+00 | ||
Methylation in Case |
2.51E-01 (Median) | Methylation in Control | 1.05E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg18771173) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.94E+00 | Statistic Test | p-value: 1.37E-05; Z-score: 2.15E+00 | ||
Methylation in Case |
1.45E-01 (Median) | Methylation in Control | 7.49E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg11355135) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.32E+00 | Statistic Test | p-value: 1.93E-05; Z-score: 1.47E+00 | ||
Methylation in Case |
3.67E-01 (Median) | Methylation in Control | 2.78E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg05311412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.43E+00 | Statistic Test | p-value: 2.03E-04; Z-score: 1.29E+00 | ||
Methylation in Case |
1.23E-01 (Median) | Methylation in Control | 8.62E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC5A7 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg14613271) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 4.47E-04; Z-score: 9.21E-01 | ||
Methylation in Case |
1.79E-01 (Median) | Methylation in Control | 1.43E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
5'UTR (cg06696917) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.30E-02; Z-score: -2.67E-01 | ||
Methylation in Case |
7.34E-02 (Median) | Methylation in Control | 7.73E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg10569606) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.90E+00 | Statistic Test | p-value: 3.33E-51; Z-score: 9.62E+00 | ||
Methylation in Case |
3.26E-01 (Median) | Methylation in Control | 6.65E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg03049846) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 7.27E-33; Z-score: -4.29E+00 | ||
Methylation in Case |
5.25E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg01792749) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 5.10E-04; Z-score: -1.03E+00 | ||
Methylation in Case |
5.63E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg10333311) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 3.46E-03; Z-score: 8.65E-01 | ||
Methylation in Case |
7.06E-01 (Median) | Methylation in Control | 6.44E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
5'UTR (cg13598790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.44E+00 | Statistic Test | p-value: 8.23E-03; Z-score: 2.34E+00 | ||
Methylation in Case |
4.03E-02 (Median) | Methylation in Control | 2.81E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
5'UTR (cg14411266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.57E+00 | Statistic Test | p-value: 1.74E-02; Z-score: 3.34E+00 | ||
Methylation in Case |
3.26E-01 (Median) | Methylation in Control | 9.11E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
TSS1500 (cg16729160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 4.01E+00 | Statistic Test | p-value: 3.13E-02; Z-score: 4.40E+01 | ||
Methylation in Case |
2.61E-01 (Median) | Methylation in Control | 6.51E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
TSS200 (cg25212131) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 3.46E-02; Z-score: 2.06E+00 | ||
Methylation in Case |
6.94E-01 (Median) | Methylation in Control | 6.16E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
1stExon (cg04592706) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.18E-02; Z-score: 2.14E+00 | ||
Methylation in Case |
9.57E-01 (Median) | Methylation in Control | 9.35E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
Body (cg20741386) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 8.85E-03; Z-score: 4.12E+00 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 8.48E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.65E-02; Z-score: 2.01E+00 | ||
Methylation in Case |
8.38E-01 (Median) | Methylation in Control | 6.97E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
Body (cg09767076) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 1.88E-02; Z-score: 1.86E+00 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 6.10E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC5A7 in prostate cancer | [ 12 ] | |||
Location |
Body (cg13917287) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 4.71E-02; Z-score: 1.30E+00 | ||
Methylation in Case |
9.42E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Significant hypermethylation of SLC5A7 in prostate cancer than that in healthy individual | ||||
Studied Phenotype |
Prostate cancer [ICD-11:2C82] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.49E-23; Fold-change: 0.355725753; Z-score: 12.37408655 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Papillary thyroid cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS1500 (cg17679621) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 4.81E-05; Z-score: 9.10E-01 | ||
Methylation in Case |
1.96E-01 (Median) | Methylation in Control | 1.61E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS1500 (cg03983336) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 5.08E-05; Z-score: 1.38E+00 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 6.78E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC5A7 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.18E-04; Z-score: -7.16E-01 | ||
Methylation in Case |
9.25E-01 (Median) | Methylation in Control | 9.36E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC5A7 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS200 (cg26001902) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 3.32E-02; Z-score: 3.31E-01 | ||
Methylation in Case |
9.45E-02 (Median) | Methylation in Control | 8.56E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC5A7 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.39E-06; Z-score: -9.42E-01 | ||
Methylation in Case |
8.94E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC5A7 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg14772660) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.58E-03; Z-score: -6.31E-01 | ||
Methylation in Case |
8.94E-01 (Median) | Methylation in Control | 9.08E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in systemic lupus erythematosus | [ 14 ] | |||
Location |
TSS1500 (cg22415472) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.45E-03; Z-score: -1.64E-01 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 8.68E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in systemic lupus erythematosus | [ 14 ] | |||
Location |
Body (cg05099596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 8.89E-03; Z-score: -2.12E-01 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC5A7 in panic disorder | [ 15 ] | |||
Location |
TSS200 (cg05311412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.86E-01 | Statistic Test | p-value: 4.15E-02; Z-score: -1.04E-01 | ||
Methylation in Case |
-3.45E+00 (Median) | Methylation in Control | -3.40E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC5A7 in panic disorder | [ 15 ] | |||
Location |
Body (cg14772660) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 2.60E-03; Z-score: -4.20E-01 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 7.10E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Acute myeloid leukemia |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC5A7 in acute myeloid leukemia than that in healthy individual | ||||
Studied Phenotype |
Acute myeloid leukemia [ICD-11:2A60] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.16E-10; Fold-change: 0.268524828; Z-score: 1.782379141 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Arterial aneurysm |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC5A7 in arterial aneurysm than that in healthy individual | ||||
Studied Phenotype |
Arterial aneurysm [ICD-11:BD51] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.041071028; Fold-change: 0.200615629; Z-score: 1.201622885 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Medulloblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Moderate hypermethylation of SLC5A7 in medulloblastoma than that in healthy individual | ||||
Studied Phenotype |
Medulloblastoma [ICD-11:2A00.10] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 3.45E-84; Fold-change: 0.284692785; Z-score: 3.43781753 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Glioblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in glioblastoma than that in healthy individual | ||||
Studied Phenotype |
Glioblastoma [ICD-11:2A00.00] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 5.09E-07; Fold-change: 0.488277974; Z-score: 1.632505164 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.55E-29; Fold-change: 0.646338693; Z-score: 2.989648066 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Malignant astrocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in malignant astrocytoma than that in healthy individual | ||||
Studied Phenotype |
Malignant astrocytoma [ICD-11:2A00.12] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 2.09E-45; Fold-change: 0.419423536; Z-score: 2.431163165 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Melanoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in melanoma than that in healthy individual | ||||
Studied Phenotype |
Melanoma [ICD-11:2C30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 0.000337613; Fold-change: 0.415145763; Z-score: 1.789280778 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Oligodendroglial tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in oligodendroglial tumour than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglial tumour [ICD-11:2A00.Y1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 5.85E-15; Fold-change: 0.467967268; Z-score: 20.16011341 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 3.96E-25; Fold-change: 0.537552899; Z-score: 2.486457956 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Prostate cancer metastasis |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in prostate cancer metastasis than that in healthy individual | ||||
Studied Phenotype |
Prostate cancer metastasis [ICD-11:2.00E+06] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 1.60E-08; Fold-change: 0.504448802; Z-score: 19.15159428 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
Gastric cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SLC5A7 in gastric cancer than that in adjacent tissue | ||||
Studied Phenotype |
Gastric cancer [ICD-11:2B72] | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value: 5.43E-30; Fold-change: 0.356816744; Z-score: 39.55765806 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
microRNA |
|||||
Unclear Phenotype |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-192 directly targets SLC5A7 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-192 | miRNA Mature ID | miR-192-3p | ||
miRNA Sequence |
CUGCCAAUUCCAUAGGUCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-323b directly targets SLC5A7 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-323b | miRNA Mature ID | miR-323b-3p | ||
miRNA Sequence |
CCCAAUACACGGUCGACCUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-329 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-329 | miRNA Mature ID | miR-329-3p | ||
miRNA Sequence |
AACACACCUGGUUAACCUCUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-362 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-362 | miRNA Mature ID | miR-362-3p | ||
miRNA Sequence |
AACACACCUAUUCAAGGAUUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-3659 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3659 | miRNA Mature ID | miR-3659 | ||
miRNA Sequence |
UGAGUGUUGUCUACGAGGGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-3941 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3941 | miRNA Mature ID | miR-3941 | ||
miRNA Sequence |
UUACACACAACUGAGGAUCAUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-4658 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4658 | miRNA Mature ID | miR-4658 | ||
miRNA Sequence |
GUGAGUGUGGAUCCUGGAGGAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-4789 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4789 | miRNA Mature ID | miR-4789-3p | ||
miRNA Sequence |
CACACAUAGCAGGUGUAUAUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-5589 directly targets SLC5A7 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5589 | miRNA Mature ID | miR-5589-3p | ||
miRNA Sequence |
UGCACAUGGCAACCUAGCUCCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-5692a directly targets SLC5A7 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5692a | miRNA Mature ID | miR-5692a | ||
miRNA Sequence |
CAAAUAAUACCACAGUGGGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-574 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-574 | miRNA Mature ID | miR-574-5p | ||
miRNA Sequence |
UGAGUGUGUGUGUGUGAGUGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-603 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-603 | miRNA Mature ID | miR-603 | ||
miRNA Sequence |
CACACACUGCAAUUACUUUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-6790 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6790 | miRNA Mature ID | miR-6790-5p | ||
miRNA Sequence |
GUGAGUGUGGAUUUGGCGGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-8485 directly targets SLC5A7 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-8485 | miRNA Mature ID | miR-8485 | ||
miRNA Sequence |
CACACACACACACACACGUAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.